Capricor Therapeutics | CAPR - Operating Expenses


Capricor Therapeutics reported $29.16M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Bioline Rx USD 2.63M 24K Sep/2025
Capricor Therapeutics USD 29.16M 2.87M Dec/2025
Cipla INR 59.27B 1.71B Mar/2026
Cytokinetics USD 200.58M 4.46M Mar/2026
Geron USD 52.07M 6.73M Mar/2026
Grifols EUR 1.99B 217.4M Dec/2025
Immunic USD 23.33M 2.67M Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Prothena USD 27.23M 14.95M Dec/2025
PTC Therapeutics USD 226.66M 19.64M Mar/2026
Sarepta Therapeutics USD 372.37M 480.65M Mar/2026